Our senior partner Prof. Ehlers in an interview with Business Insider regarding the suspension of patent protection for Corona vaccines that has been brought up for discussion: https://www.businessinsider.de/wissenschaft/gesundheit/experte-patent-aussetzung-waere-schwerer-gesetzesbruch/
Ehlers, Ehlers & Partner is again listed in the renowned “Legal 500 Europe, Middle East and Africa (EMEA)” ranking. The team around Prof. Ehlers and Dr. Rybak, who are mentioned by name, is one of the leading law firms in…
We are pleased to announce once again that our senior partner Prof. Ehlers has been recognised in the new edition of the respected ranking “Chambers Europe” in the category #Healthcare in #Germany (Band 4). In the citation, #Chambers emphasises his…
Ehlers, Ehlers & Partner was again awarded in the category “Biotechnology & Pharmaceutical”.
